Biomarker Exploration in Aging, Cognition and Neurodegeneration
The BEACoN Study- Biomarker Exploration in Aging, Cognition and Neurodegeneration
University of California, Irvine
300 participants
May 1, 2018
INTERVENTIONAL
Conditions
Summary
The purpose of this research study is to understand the factors that underlie changes in thinking and memory with increasing age. The investigators will test the usefulness of MRI, PET, and cognitive testing in detecting subtle changes in the brain that precede cognitive decline. An addendum to this study includes additional PET scans to examine the relationship between tau protein in the brain and cognitive decline. Tau is a protein that is known to form tangles in the areas of the brain important for memory, and these tau tangles are a hallmark of Alzheimer's disease. This sub-study research aims to look at the tau accumulation in the brain using an investigational drug called MK-6240, which is a radio tracer that gets injected prior to a positron emission tomography (PET) scan.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Amyloid Positron Emission Tomography scan using radio tracer florbetapir-F18
Tau Positron Emission Tomography scan using radio tracer MK-6240
A battery of clinical neuropsychological assessments and computerized cognitive tasks will be used to test participants' memory and cognitive abilities.
High-resolution structural, functional, and diffusion Magnetic Resonance Imaging scans will be collected during the study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03860857